The case for achieving ancillary/raw material consistency and flexibility of deliverability for manufacturing partnership at scale

The nascent field of cell and gene therapy is poised to experience growing pains that other, later-stage therapeutic industries have already come to know.

This eBook, created in partnership with Bio-Techne, explores the anticipated challenges to the industry’s growing commercialisable pipeline, as well as the way in which those challenges may be considered unique to advanced therapy medicinal products (ATMPs).